YAP1 and breast carcinoma: Intriguingly, by integrating specific genes, miRNA expression patterns, and transcriptional profiles, we found that breast cancer patients with high SPAG5 expression exhibit an activated YAP/TAZ signature, implying that aberrant activation of the two key transducers either independently or dependently from their role in the Hippo pathway enhances SPAG5’s oncogenic activity.